Preclinical immunogenicity of the LP.8.1-adapted BNT162b2 COVID-19 vaccine
{{output}}
SARS-CoV-2 evolution toward antigenically distinct lineages drives escape from host immunity. JN.1 lineage derivatives have recently dominated the global epidemiologic landscape. In preclinical models, an LP.8.1-adapted BNT162b2 vaccine elicited higher serum n... ...
